Last Close
8.50
Jul 30 • 3:59 PM ET Dollar change+1.48 Percentage change(21.08%)
Aftermarket Close
8.43
Aftermarket • 4:55 PM ET Dollar change-0.07 Percentage change(-0.82%)
Index
-
Market Cap
97.70M
Enterprise Value
92.20M
Income
-238.37M
Sales
0.05M
Book/sh
7.27
Cash/sh
0.60
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
14
IPO
Apr 09, 2010
P/E
-
Forward P/E
-
PEG
-
P/S
1954.03
P/B
1.17
P/C
14.10
P/FCF
-
EV/EBITDA
-
EV/Sales
1844.03
Quick Ratio
8.89
Current Ratio
8.89
Debt/Eq
0.04
LT Debt/Eq
0.02
Option/Short
No / Yes
EPS (ttm)
-147.99
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS past 3/5Y
49.83% 54.21%
Sales past 3/5Y
-56.34% -36.90%
EPS Y/Y TTM
-431.31%
Sales Y/Y TTM
-96.26%
EPS Q/Q
93.37%
Sales Q/Q
-67.99%
Insider Own
31.27%
Insider Trans
0.00%
Inst Own
2.96%
Inst Trans
10.89%
ROA
-932.76%
ROE
-1187.68%
ROIC
-581.45%
Gross Margin
-1371.09%
Oper. Margin
-58805.87%
Profit Margin
-474035.48%
SMA20
14.70%
SMA50
19.56%
SMA200
50.32%
Trades
Shs Outstand
11.49M
Shs Float
7.90M
52W High
32.10 -73.52%
52W Low
1.03 725.24%
Volatility
12.92% 13.58%
ATR (14)
1.02
RSI (14)
57.52
Beta
3.45
Rel Volume
1.16
Avg Volume
428.81K
Volume
499,360
Perf Week
15.49%
Perf Month
12.14%
Perf Quarter
50.71%
Perf Half Y
152.23%
Perf YTD
18.88%
Perf Year
-27.51%
Perf 3Y
-89.43%
Perf 5Y
-97.49%
Perf 10Y
-99.92%
Prev Close
7.02
Price
8.50
Change
21.08%
Date Action Analyst Rating Change Price Target Change
Aug-19-24Initiated H.C. Wainwright Buy $3
Jul-27-26 08:30AM
Jul-22-26 08:30AM
Jul-07-26 08:30AM
Jun-16-26 03:40PM
08:30AM
08:30AM Loading…
May-27-26 08:30AM
May-25-26 09:00PM
May-15-26 05:59PM
May-11-26 08:30AM
May-04-26 08:30AM
Apr-28-26 11:05AM
Apr-23-26 10:50AM
Apr-22-26 10:44AM
10:30AM
08:00AM
08:00AM Loading…
Apr-20-26 08:00AM
Apr-06-26 08:00AM
Apr-01-26 03:01PM
10:30AM
08:00AM
Mar-31-26 04:30PM
Mar-27-26 08:45AM
Mar-17-26 08:45AM
Feb-24-26 08:00AM
Feb-09-26 08:00AM
Jan-12-26 09:00AM
Dec-12-25 08:00AM
Dec-02-25 08:00AM
Nov-14-25 05:12PM
Oct-21-25 04:32AM
08:00AM Loading…
Oct-14-25 08:00AM
Oct-08-25 09:00AM
Sep-30-25 07:32AM
Sep-29-25 05:33PM
09:07AM
Sep-25-25 08:00AM
Sep-04-25 09:00AM
Aug-14-25 07:00AM
Jul-15-25 09:00AM
Jul-08-25 09:00AM
Jun-12-25 08:30AM
May-27-25 08:35AM
May-22-25 03:12PM
11:05AM
08:15AM
May-20-25 08:30AM
May-15-25 07:00AM
May-08-25 07:05PM
Apr-29-25 08:45AM
Apr-15-25 08:00AM
Apr-05-25 12:10PM
Apr-04-25 09:40AM
Apr-01-25 07:00AM
Mar-27-25 05:33PM
Mar-25-25 07:00AM
Mar-20-25 07:00AM
Mar-03-25 09:15AM
09:00AM
Feb-19-25 05:20PM
10:10AM
08:00AM
Feb-18-25 03:41PM
08:00AM
Feb-10-25 08:00AM
Jan-16-25 08:00AM
Jan-07-25 09:15AM
Jan-06-25 09:15AM
09:10AM
Dec-03-24 07:00AM
Nov-13-24 07:00AM
Oct-09-24 06:23PM
Sep-05-24 08:00AM
Aug-27-24 08:00AM
Aug-14-24 07:00AM
Aug-13-24 10:52PM
07:00AM
Aug-07-24 07:00AM
Jul-26-24 08:00AM
Jul-25-24 07:00AM
Jun-28-24 06:00AM
Jun-11-24 08:00AM
Jun-04-24 08:42AM
May-29-24 07:00AM
May-28-24 07:00AM
May-15-24 09:52AM
07:00AM
May-10-24 07:00AM
May-08-24 06:45AM
May-06-24 07:28AM
May-01-24 07:31AM
Apr-30-24 04:05PM
Apr-25-24 09:17AM
Apr-24-24 04:05PM
Apr-02-24 10:31AM
Mar-28-24 11:52PM
05:28PM
Feb-21-24 04:05PM
Jan-02-24 07:00AM
Nov-15-23 02:17PM
Nov-14-23 07:00AM
Axe Compute, Inc. engages in the provision of graphics processing unit compute capacity for artificial intelligence and other complex computing workloads. It operates through the following segments: Compute Services and Treasury Management segment, and Drug Discovery Services segment. The Compute Services and Treasury Management segment provides services that include access to GPU compute capacity and manage the ATH Treasury Strategy. The Drug Discovery Services segment provides services that include the application of AI, creation of specific 3D culture models used in drug development. The company was founded by Lawrence W. Gadbaw, Peter L. Morawetz, and Jeffrey K. Drogue on April 23, 2002 and is headquartered in Pittsburgh, PA.
CEO & DirectorMr. Christopher Miglino
PresidentMr. Kyle Okamoto
Chief Financial OfficerMr. Jeremy Yaukey-Witter
Vice President of Marketing & Investor RelationsErin McMahon
General CounselMs. Sara Turken J.D.